BBVA
TXMD icon

Banco Bilbao Vizcaya Argentaria’s TherapeuticsMD TXMD Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,800
Closed -$175K – 753
2020
Q2 		$175K Buy
2,800
+2,000
+250% +$116K 0.01% 723
2020
Q1 		$42K Hold
800
– – ﹤0.01% 667
2019
Q4 		$96K Buy
+800
New +$115K ﹤0.01% 705

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's TXMD Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of TherapeuticsMD (TXMD) in Q3 2020, closing a stake of 2,800 shares — an estimated $175K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in TXMD in Q4 2019 and held it in 3 quarters. The position peaked at $175K in Q2 2020. 142 funds tracked by Wall St. Rank hold TXMD as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining TherapeuticsMD position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 2,800 TherapeuticsMD shares in Q3 2020, an estimated $175K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in TherapeuticsMD in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's TherapeuticsMD position peaked at $175K in Q2 2020.
  • 142 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.